Animal health giant Elanco declares blockbuster Seresto collars “vindicated” by recent EPA finding, but CEO continues to evade questions

Per Elanco (NYSE: ELAN) spokeswoman Colleen Dekker:

“Finally vindicated,” Elanco’s spokeswoman Colleen Dekker told TCR late yesterday. She added:

“EPA has completed their review and confirmed Seresto continues to meet EPA’s standards for registration under FIFRA. As such, they have denied Center for Biological Diversity’s petition to cancel the product. We have worked with EPA to develop a comprehensive stewardship program that we believe should be applied to raise the bar on the ongoing pharmacoviglience monitoring for the entire collar class of products.”

More to follow.


USA Today ambushes Seresto again with dubious story, failing to seek comment